Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
about
Levosimendan: current data, clinical use and future developmentLevosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients.Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.Role of PiCCO monitoring for the integrated management of neurogenic pulmonary edema following traumatic brain injury: A case report and literature review.Effects of milrinone on serum IL-6, TNF-α, Cys-C and cardiac functions of patients with chronic heart failure
P2860
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Levosimendan versus dobutamine ...... randomized controlled trials.
@en
type
label
Levosimendan versus dobutamine ...... randomized controlled trials.
@en
prefLabel
Levosimendan versus dobutamine ...... randomized controlled trials.
@en
P2093
P2860
P356
P1476
Levosimendan versus dobutamine ...... randomized controlled trials.
@en
P2093
Guo-lian Xia
Li-quan Huang
Mei-fei Zhu
Rong-lin Jiang
Xuan Huang
Yi-hui Zhi
P2860
P2888
P304
P356
10.1631/JZUS.B1200290
P577
2013-05-01T00:00:00Z
P6179
1042709767